These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8358345)

  • 21. [123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primates.
    Scanley BE; Gandelman MS; Laruelle M; Al-Tikriti MS; Baldwin RM; Zoghbi SS; Hoffer PB; Wang S; Neumeyer JL; Innis RB
    Nucl Med Biol; 2000 Jan; 27(1):13-21. PubMed ID: 10755641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography.
    Hiltunen J; Akerman KK; Kuikka JT; Bergström KA; Halldin C; Nikula T; Räsänen P; Tiihonen J; Vauhkonen M; Karhu J; Kupila J; Länsimies E; Farde L
    Eur J Nucl Med; 1998 Jan; 25(1):19-23. PubMed ID: 9396870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.
    Scherfler C; Donnemiller E; Schocke M; Dierkes K; Decristoforo C; Oberladstätter M; Kolbitsch C; Zschiegner F; Riccabona G; Poewe W; Wenning G
    Neuroimage; 2002 Sep; 17(1):128-41. PubMed ID: 12482072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
    Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
    J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions.
    Laruelle M; Giddings SS; Zea-Ponce Y; Charney DS; Neumeyer JL; Baldwin RM; Innis RB
    J Neurochem; 1994 Mar; 62(3):978-86. PubMed ID: 8113817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
    Booij J; Andringa G; Rijks LJ; Vermeulen RJ; De Bruin K; Boer GJ; Janssen AG; Van Royen EA
    Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
    Ryding E; Lindström M; Brådvik B; Grabowski M; Bosson P; Träskman-Bendz L; Rosén I
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.
    Kim SE; Lee WY; Choe YS; Kim JH
    Neurol Res; 1999 Apr; 21(3):255-61. PubMed ID: 10319333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [123I]beta-CIT SPECT visualizes dopamine transporter loss in de novo parkinsonian patients.
    Müller T; Farahati J; Kuhn W; Eising EG; Przuntek H; Reiners C; Coenen HH
    Eur Neurol; 1998; 39(1):44-8. PubMed ID: 9476723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging.
    Kuikka JT; Baulieu JL; Hiltunen J; Halldin C; Bergström KA; Farde L; Emond P; Chalon S; Yu M; Nikula T; Laitinen T; Karhu J; Tupala E; Hallikainen T; Kolehmainen V; Mauclaire L; Maziere B; Tiihonen J; Guilloteau D
    Eur J Nucl Med; 1998 May; 25(5):531-4. PubMed ID: 9575250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
    Ahlskog JE; Uitti RJ; O'Connor MK; Maraganore DM; Matsumoto JY; Stark KF; Turk MF; Burnett OL
    Mov Disord; 1999 Nov; 14(6):940-6. PubMed ID: 10584667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM.
    Acton PD; Kung MP; Mu M; Plössl K; Hou C; Siciliano M; Oya S; Kung HF
    Eur J Nucl Med; 1999 Aug; 26(8):854-61. PubMed ID: 10436198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters.
    Fujita M; Takatoku K; Matoba Y; Nishiura M; Kobayashi K; Inoue O; Nishimura T
    Eur J Nucl Med; 1996 Apr; 23(4):431-6. PubMed ID: 8612664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.
    Laruelle M; Wallace E; Seibyl JP; Baldwin RM; Zea-Ponce Y; Zoghbi SS; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):982-94. PubMed ID: 7929662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT.
    Malison RT; Vessotskie JM; Kung MP; McElgin W; Romaniello G; Kim HJ; Goodman MM; Kung HF
    J Nucl Med; 1995 Dec; 36(12):2290-7. PubMed ID: 8523122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human biodistribution and dosimetry of iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A; Innis RB; Wisniewski G; Baldwin RM; Neumeyer JL; Seibyl JP
    Eur J Nucl Med; 1997 Nov; 24(11):1422-5. PubMed ID: 9371877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
    Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE
    J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter by SPECT (II): Tracer kinetics in the brain].
    Takano K; Matsumura K; Watanabe Y; Yamada T; Kubo H; Naitou Y; Narita Y; Kuzuhara S; Takeda K
    Kaku Igaku; 1999 Dec; 36(9):1013-22. PubMed ID: 10659586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.